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794Contralateral microemboli following carotid artery
stenting in patients with a contralateral internal
carotid artery occlusion
Kevin Casey, MD,a Elizabeth Hitchner, MA,c Barton Lane, MD,c andWei Zhou, MD,b,c San Diego, Stanford,
and Palo Alto, Calif
Subclinical microembolization identiﬁed on diffusion-weighted magnetic resonance imaging is recognized as an impor-
tant outcome measure for carotid revascularization procedures. It is generally believed that arch manipulation is the
primary reason for developing microemboli in the contralateral hemisphere during carotid artery stenting. However, we
identiﬁed three patients who developed postprocedure microemboli of the contralateral hemisphere despite a known
chronic contralateral internal carotid artery occlusion. Our cases highlight that ipsilateral microemboli may be an
underappreciated but an important source of contralateral lesions through patent intracranial collateral pathways. (J Vasc
Surg 2013;58:794-7.)Subclinical microembolization identiﬁed on diffusion-
weighted magnetic resonance imaging (DWI) is increas-
ingly recognized as an important outcome measure
following carotid artery stenting (CAS). Embolic events
are not isolated to the ipsilateral cerebrum; rather, they
have also been detected with a high frequency in the
contralateral hemisphere.1,2 The common hypothesis is
that small debris originating from the aortic arch and
cardiac sources travels via a patent contralateral internal
carotid artery (ICA) to the contralateral cerebrum. We
herein describe three patients with chronic contralateral
ICA occlusions who nonetheless sustained microemboli
to the contralateral cerebral hemisphere following CAS.
CASE REPORT
Over a period of 7 years, a total of 262 CAS procedures were
performed and all patients received pre- andpostproceduremagnetic
resonance imaging (MRI) when appropriate. Among 14 patients
with a known chronic contralateral ICA occlusion who underwent
CAS, three patients demonstrated new contralateral microembolithe Department of General Surgery, Division of Vascular Surgery,
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high cardiac risk and the third had a high lesion that deemed him
a better candidate for an endovascular approach. All three con-
tralateral ICA occlusions were identiﬁed on preoperative duplex
ultrasound and magnetic resonance angiogram evaluations. Time-
of-ﬂight MRIs also demonstrated patent anterior communicating
arteries (ACOMs) in two patients and prominent posterior commu-
nicating arteries (PCOMs) in the other patient (Fig 1, A and B).
The procedures were performed by an experienced vascular
surgeon and a vascular surgery fellow as described previously.3
Brieﬂy, following access and early systemic anticoagulation (100
u/kg intravenous heparin), an arch aortogram was performed
when necessary. The carotid artery was cannulated with a telescopic
technique4 followed by routine placement of an embolic protec-
tion device (EPD). One patient required prestent angioplasty
using 2- and 3-mm angioplasty balloons to enable stent traversal.
Stents were deployed and poststent balloon angioplasty was stan-
dard. One patient required intravenous administration of atropine
and neosynephrine for persistent hypotension. All three patients
remained neurologically intact. DWI evaluations were performed
prior to discharge the following day. Each patient was discharged
on 6 weeks of clopidogrel, daily aspirin, and a statin. All three
patients did well without neurologic deﬁcit at 1- and 6-month
follow-up evaluations.
New ipsilateral lesions were identiﬁed in the occipital and pari-
etal lobes of one patient, parietal lobe of another, and middle cere-
bral artery distribution of the third. Contralateral microemboli
were identiﬁed in the frontal lobes of two patients and in the distri-
bution of the middle cerebral artery of the third despite contralat-
eral carotid occlusions (Figs 2 and 3). These lesions were
determined to be acute based on DWI images and apparent diffu-
sion coefﬁcient maps.
DISCUSSION
Three patients demonstrated evidence of new contra-
lateral microemboli following CAS despite the presence
of chronically occluded contralateral ICA and the absence
of neurologic symptoms. Unlike previous studies and
Fig 1. A, Circle of Willis, demonstrating patent anterior communicating artery (ACOM). B, Circle of Willis,
demonstrating patent posterior communicating artery (PCOM).
Fig 2. Pre- and postprocedure diffusion-weighted magnetic resonance imaging (DWI) demonstrating a new lesion.
Table. Patient characteristics
Patient 1 2 3
Age, sex 77 M 69 M 78 M
% stenosis 70%-80% 70%-80% 90%-99%
Atrial ﬁbrillation N N Y
Arch Type II Type II Type I
Stent Xact Xact Wallstent
EPD Emboshield Emboshield EZ-Filterwire
Prestent angioplasty N N Y
Ipsilateral microemboli Occipital, parietal Parietal MCA
Contralateral microemboli Frontal Frontal MCA
EPD, Embolic protection device; MCA, middle cerebral artery.
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evidence of another major underappreciated source of
contralateral hemispheric microemboli.
Periprocedural subclinical embolic events during CAS
have been the focus of considerable debate since itsinception. The reported incidence of microemboli is not
insigniﬁcant.1,2,5,6 Embolic protection device, ﬂow reversal
systems, and dextran administration have all been imple-
mented with varying degrees of success in an attempt to
decrease the incidence of microemboli.7 A substantial
Fig 3. Pre- and postprocedure diffusion-weighted magnetic resonance imaging (DWI) demonstrating a new lesion.
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strated in the contralateral hemisphere.1,2 Although the
long-term neurologic consequence of these events remains
uncertain, there is a commitment to preventing their occur-
rence secondary to concern of an increased risk of vascular
dementia.8
There remain multiple hypotheses for the formation of
contralateral microemboli. The main culprit appears to be
wire manipulation in and around the diseased aortic arch.
Another theory suggests that a cardiac source may be the
nidus for contralateral embolic events. Direct embolization
from these two sources was unlikely in our patients given
that these patients had contralateral chronic ICA occlu-
sion. The ICA stump syndrome, in which the external
carotid artery serves as a conduit for emboli from the prox-
imal ICA occlusion, is a known entity with an annual ipsi-
lateral stroke risk of up to 5%.9-12 Some authors have
demonstrated continued distal embolization from an
occluded ICA.13 However, preoperative DWI evaluations
did not demonstrate embolic sequelae before the CAS
procedures. These new lesions in both hemispheres were
identiﬁed within 48 hours of the procedure and were
consistent with the radiologic appearance of acute lesions,
suggesting procedure-related emboli. Another potential
source is a patent contralateral vertebral artery. Although
this is plausible, the patient with ipsilateral occipital lesions
had a contralateral lesion in the frontal lobe, a well-
developed ACOM, but absence of PCOM, which make
the vertebral source unlikely. Two of our patients also
demonstrated new ipsilateral microemboli in the frontal
lobes, and all contralateral lesions were in the distribution
of anterior circulation, thereby raising the suspicion that
the ipsilateral ICA and anterior pathway collaterals remain
the source.
Our cases highlight a major source of subclinical em-
bolization to the contralateral hemisphere, particularly
when the embolic debris is small. We believe this occurred
through intercerebral collateralization whereby particlestraveled via interhemisphere communicating arteries.
An intact Circle of Willis occurs in 21% to 50% of
patients.14-16 There are multiple posterior-anterior and
interhemispheric collateral pathways. The anterior path-
way, intact in 99% of patients,17 allows blood ﬂow across
the ACOM from the anterior cerebral artery. Although
absent or hypoplastic in up to 30% of the population,14
the PCOM is another recognized important source of
primary collateral circulation for the contralateral middle
and anterior cerebral territories. A small (<1 mm in diam-
eter) ipsilateral PCOM is shown to be an independent risk
factor for ischemic cerebral infarction in patients with ICA
occlusions.18 Our patients had asymptomatic contralateral
internal carotid occlusions, which likely contributed to
their well-developed PCOM. Unfortunately, the ACOM
or PCOM may potentially serve as a major highway for
embolic particles as well.19
CONCLUSIONS
Contralateral cerebral embolization during CAS is
not rare. This series demonstrates that the role of the
Circle of Willis in interhemispheric embolization may be
underestimated during CAS. We herein provide structural
evidence of intracranial primary collateral pathways,
particularly via the ACOM and PCOM, as important
sources of interhemispheric microembolization. Further-
more, it underscores the need for continued meticulous
procedural technique and improved embolic protection
during CAS.
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